20-gauge safer than 25-gauge surgery

Article

Patients undergoing 25-gauge vitreoretinal surgery are more likely to experience postoperative serous choroidal effusion and hypotony than patients undergoing 20-gauge procedures.

Patients undergoing 25-gauge vitreoretinal surgery are more likely to experience postoperative serous choroidal effusion and hypotony than patients undergoing 20-gauge procedures, according to a report published in the October issue of Retina.

Saad Shaikh and co-workers from Rollins College and Central Florida Retina Consultants, Florida, US compared complication rates between two groups of 129 eyes treated with primary 25- or 20-gauge vitreoretinal surgery. Average follow-up was 9.1 months and 14.3 months in the 25- and 20-gauge groups, respectively.

The researchers found that both groups had similar rates of intraoperative complications, which were mainly rhematogenous in nature. A total of 46% of patients, in both groups, experienced cataract progression. Eyes treated with 25-gauge procedures, had a significantly higher incidence of postoperative complications; 7.9% developed hypotony and serous choroidal effusions compared with just 1.6% of the 20-gauge treated eyes. Two eyes in the 25-gauge group developed endophthalmitis.

It was the conclusion of the authors that 25-gauge surgery is more likely to result in postoperative complications than 20-gauge surgery.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
© 2025 MJH Life Sciences

All rights reserved.